Christine Zhang

Christine H. Zhang is an accomplished professional with extensive experience in corporate strategy and consulting in the biotech and healthcare sectors. Currently serving as Senior Director of Corporate Strategy at both BridgeBio and Eidos Therapeutics since 2021, Christine has also held positions as Director and Associate Director in the same field. Additionally, Christine operates Zhang BioConsulting LLC as a Bio + Tech Consultant. Previous experience includes a role in healthcare private equity at TPG Capital and investment banking focused on biotech at Goldman Sachs. Christine holds a BA in Applied Mathematics and Computer Science from Harvard University.